Literature DB >> 22258237

HIV cell-to-cell transmission requires the production of infectious virus particles and does not proceed through env-mediated fusion pores.

Blandine Monel1, Elodie Beaumont, Daniela Vendrame, Olivier Schwartz, Denys Brand, Fabrizio Mammano.   

Abstract

Direct cell-to-cell transmission of human immunodeficiency virus (HIV) is a more potent and efficient means of virus propagation than infection by cell-free virus particles. The aim of this study was to determine whether cell-to-cell transmission requires the assembly of enveloped virus particles or whether nucleic acids with replication potential could translocate directly from donor to target cells through envelope glycoprotein (Env)-induced fusion pores. To this end, we characterized the transmission properties of viruses carrying mutations in the matrix protein (MA) that affect the incorporation of Env into virus particles but do not interfere with Env-mediated cell-cell fusion. By use of cell-free virus, the infectivity of MA mutant viruses was below the detection threshold both in single-cycle and in multiple-cycle assays. Truncation of the cytoplasmic tail (CT) of Env restored the incorporation of Env into MA mutant viruses and rescued their cell-free infectivity to different extents. In cell-to-cell transmission assays, MA mutations prevented HIV transmission from donor to target cells, despite efficient Env-dependent membrane fusion. HIV transmission was blocked at the level of virus core translocation into the cytosol of target cells. As in cell-free assays, rescue of Env incorporation by truncation of the Env CT restored the virus core translocation and cell-to-cell infectivity of MA mutant viruses. These data show that HIV cell-to-cell transmission requires the assembly of enveloped virus particles. The increased efficiency of this infection route may thus be attributed to the high local concentrations of virus particles at sites of cellular contacts rather than to a qualitatively different transmission process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22258237      PMCID: PMC3302491          DOI: 10.1128/JVI.06478-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

Review 1.  Intracellular destinies: degradation, targeting, assembly, and endocytosis of HIV Gag.

Authors:  Kevin C Klein; Jonathan C Reed; Jaisri R Lingappa
Journal:  AIDS Rev       Date:  2007 Jul-Sep       Impact factor: 2.500

2.  Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail.

Authors:  T Murakami; E O Freed
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Mutation of critical serine residues in HIV-1 matrix result in an envelope incorporation defect which can be rescued by truncation of the gp41 cytoplasmic tail.

Authors:  Ajay K Bhatia; Rajnish Kaushik; Nancy A Campbell; Suzanne E Pontow; Lee Ratner
Journal:  Virology       Date:  2008-12-06       Impact factor: 3.616

Review 4.  Role of HIV-1 Gag domains in viral assembly.

Authors:  Suzanne Scarlata; Carol Carter
Journal:  Biochim Biophys Acta       Date:  2003-07-11

5.  Quantitative 3D video microscopy of HIV transfer across T cell virological synapses.

Authors:  Wolfgang Hübner; Gregory P McNerney; Ping Chen; Benjamin M Dale; Ronald E Gordon; Frank Y S Chuang; Xiao-Dong Li; David M Asmuth; Thomas Huser; Benjamin K Chen
Journal:  Science       Date:  2009-03-27       Impact factor: 47.728

6.  HIV-1 Assembly at the Plasma Membrane: Gag Trafficking and Localization.

Authors:  Akira Ono
Journal:  Future Virol       Date:  2009       Impact factor: 1.831

7.  Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes.

Authors:  U Schubert; K A Clouse; K Strebel
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

8.  Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains.

Authors:  F Mammano; E Kondo; J Sodroski; A Bukovsky; H G Göttlinger
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

9.  A conserved dileucine motif mediates clathrin and AP-2-dependent endocytosis of the HIV-1 envelope protein.

Authors:  Rahel Byland; Patricia J Vance; James A Hoxie; Mark Marsh
Journal:  Mol Biol Cell       Date:  2006-11-15       Impact factor: 4.138

Review 10.  Avoiding the void: cell-to-cell spread of human viruses.

Authors:  Quentin Sattentau
Journal:  Nat Rev Microbiol       Date:  2008-11       Impact factor: 60.633

View more
  26 in total

1.  Ezrin is a component of the HIV-1 virological presynapse and contributes to the inhibition of cell-cell fusion.

Authors:  Nathan H Roy; Marie Lambelé; Jany Chan; Menelaos Symeonides; Markus Thali
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

2.  HIV-1 Cell-Free and Cell-to-Cell Infections Are Differentially Regulated by Distinct Determinants in the Env gp41 Cytoplasmic Tail.

Authors:  Natasha D Durham; Benjamin K Chen
Journal:  J Virol       Date:  2015-07-01       Impact factor: 5.103

3.  Distinct functions for the membrane-proximal ectodomain region (MPER) of HIV-1 gp41 in cell-free and cell-cell viral transmission and cell-cell fusion.

Authors:  Vani G S Narasimhulu; Anna K Bellamy-McIntyre; Annamarie E Laumaea; Chan-Sien Lay; David N Harrison; Hannah A D King; Heidi E Drummer; Pantelis Poumbourios
Journal:  J Biol Chem       Date:  2018-03-01       Impact factor: 5.157

4.  Design, synthesis and evaluation of small molecule CD4-mimics as entry inhibitors possessing broad spectrum anti-HIV-1 activity.

Authors:  Francesca Curreli; Dmitry S Belov; Ranjith R Ramesh; Naisargi Patel; Andrea Altieri; Alexander V Kurkin; Asim K Debnath
Journal:  Bioorg Med Chem       Date:  2016-09-24       Impact factor: 3.641

5.  Glycosyl-Phosphatidylinositol-Anchored Anti-HIV Env Single-Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity.

Authors:  Anisha Misra; Emile Gleeson; Weiming Wang; Chaobaihui Ye; Paul Zhou; Jason T Kimata
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

6.  Neutralization resistance of virological synapse-mediated HIV-1 Infection is regulated by the gp41 cytoplasmic tail.

Authors:  Natasha D Durham; Alice W Yewdall; Ping Chen; Rebecca Lee; Chati Zony; James E Robinson; Benjamin K Chen
Journal:  J Virol       Date:  2012-05-02       Impact factor: 5.103

Review 7.  HIV cell-to-cell transmission: effects on pathogenesis and antiretroviral therapy.

Authors:  Luis M Agosto; Pradeep D Uchil; Walther Mothes
Journal:  Trends Microbiol       Date:  2015-03-09       Impact factor: 17.079

8.  Elucidating the Basis for Permissivity of the MT-4 T-Cell Line to Replication of an HIV-1 Mutant Lacking the gp41 Cytoplasmic Tail.

Authors:  Melissa V Fernandez; Huxley K Hoffman; Nairi Pezeshkian; Philip R Tedbury; Schuyler B van Engelenburg; Eric O Freed
Journal:  J Virol       Date:  2020-11-09       Impact factor: 5.103

9.  Efficient single tobamoviral vector-based bioproduction of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 in Nicotiana benthamiana plants and utility of VRC01 in combination microbicides.

Authors:  Krystal Teasley Hamorsky; Tiffany W Grooms-Williams; Adam S Husk; Lauren J Bennett; Kenneth E Palmer; Nobuyuki Matoba
Journal:  Antimicrob Agents Chemother       Date:  2013-02-12       Impact factor: 5.191

Review 10.  Cell-Free versus Cell-to-Cell Infection by Human Immunodeficiency Virus Type 1 and Human T-Lymphotropic Virus Type 1: Exploring the Link among Viral Source, Viral Trafficking, and Viral Replication.

Authors:  Hélène Dutartre; Mathieu Clavière; Chloé Journo; Renaud Mahieux
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.